Partners in Digital Health cover art

Partners in Digital Health

Partners in Digital Health

Written by: Tory Cenaj
Listen for free

About this listen

Partners in Digital Health (PDH) is a forward-reaching media and communications company, catalyzing strategic thoughts-leaders, and new era thinkers that champion the acceleration of healthcare transformation. The portfolio converges leading academics, pragmatic innovators, and practitioners around the globe to assist in the acceleration of healthcare transformation, and better outcomes for health consumers presenting evidence based fact. PDH continuously pushes the boundaries of technology innovation in scholarly publication and ecosystem practices to bring trust, transparency, and truth to its audience, publishing the peer review journals Blockchain in Healthcare Today and Telehealth and Medicine Today.Partners in Digital Health 2020 Hygiene & Healthy Living Physical Illness & Disease Politics & Government
Episodes
  • Windows to the Mind: How Your Eyes Reveal Your Brain’s Secrets
    Jan 19 2026

    Windows to the Mind: How Your Eyes Reveal Your Brain’s Secrets

    • Sai Mattapalli - Vytal.ai, Thomas Jefferson High School for Science and Technology, Alexandria, Virginia, USA
    • Rohan Kalahasty - Vytal.ai, Thomas Jefferson High School for Science and Technology, Alexandria, Virginia, USA

    In the past five years, artificial intelligence has revolutionized healthcare by enabling earlier detection, diagnosis, and treatment of diseases. A recent breakthrough involves using eye-tracking technology to identify ocular biomarkers, aiding in the early detection of conditions like Alzheimer's and neurodegenerative diseases.

    Eye movement tests, previously costly and complex, have become accessible through smartphone and laptop cameras. These tests help detect a range of conditions, from degenerative disorders to brain injuries, improving patient outcomes and facilitating telehealth.

    This technology not only benefits patients but also advances the study of brain health. By delving into neurology and treatment efficacy, it may provide insights into the causes of neurodegenerative diseases.

    The future potential of gaze tracking is promising, with non-invasive, cost-effective systems offering hope for earlier diagnosis and treatment of neurodegenerative diseases, addressing a significant gap in healthcare. The eyes are not just windows to the soul but also a gateway to the brain's health.

    Show More Show Less
    24 mins
  • Evaluating LLMs in Healthcare: A ConV2X Panel Discussion
    Jan 12 2026

    Evaluating LLMs in Healthcare: A ConV2X Panel Discussion

    • Sandeep Reddy, MBBS, MSc, PhD Director, MBA (Healthcare Management), Deakin School of Medicine, and Chairman, Medi-AI
    • Alexandre Lebrun CEO, Nabla
    • Adam Chee, PhD Chief, Smart Health Leadership Centre, Institute of Systems Science National University of Singapore
    • Moderator: Dimitris Kalogeropoulos, PhD CEO, Global Health and Digital Innovation Foundation

    How do we evaluate large language models for use in healthcare? What are the trusted frameworks for value assessment? Is automation through GPT successfully addressing the healthcare administrative and workforce crisis? What about clinical decision making? Expect a candid discussion from these experts on the implications of LLM’s and AI in Primary Care in the US and around the globe.

    Learning Outcomes • Acquire knowledge of the fundamental principles of large language models • Understand how these models are trained and deployed in a healthcare context • Learn how to assess the efficiency and effectiveness of large language models in healthcare • Understand the measures used in determining the success of these models, such as improved patient outcomes, efficiency in operations, and patient satisfaction • Learn to apply evaluation or translational frameworks in assessing the value of large language models • Gain insights into how automation, specifically through GPT, is helping to solve healthcare administrative challenges • Learn about the use of large language models in clinical decision-making • Understand the strengths and limitations of these models in making clinical decisions, administration, and the ethics

    Show More Show Less
    57 mins
  • What Is DeSci: Challenges and Market Perceptions
    Dec 22 2025

    What Is DeSci: Challenges and Market Perceptions

    Authors

    • Jelani Clarke, PhD Executive Lead, DeSci World, and Sales & Marketing Head at AminoChain
    • Filippo Frangioni Product Manager, Novo Nordisk, and Head of Partnerships at Nordic Blockchain Association
    • Jim Nasr CEO, Acoer

    Themes tackled include:

    • The perception problem: Why does DeSci still sound like sci-fi to most scientists?
    • Funding friction: Can decentralized models compete with traditional grants and venture capital?
    • Data ownership: Who really owns research data, and how can blockchain change that?
    • Regulatory roadblocks: What happens when innovation moves faster than policy?
    • Real world implementation: Beyond the hype, where is DeSci actually working today?

    From pharmaceutical giants to grassroots research collectives, these leaders shared unfiltered insights on what's holding DeSci back—and what could accelerate its adoption.

    Intrigued?

    This conversation is the first in a new podcast series launching in 2026 that will dive deeper into the decentralized science revolution. We'll explore:

    • Case studies of successful DeSci projects
    • Interviews with researchers and policy makers
    • Delve into tokenomics, DAOs, and data sovereignty
    • The intersection of AI, biotech, and decentralized systems

    The future of science is being built by innovators, technologists, and researchers willing to challenge the status quo.

    Show More Show Less
    45 mins
No reviews yet